Rosenn B, Miodovnik M, Dignan P S, Siddiqi T A, Khoury J, Mimouni F
Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Ohio.
Obstet Gynecol. 1990 Nov;76(5 Pt 1):745-9. doi: 10.1097/00006250-199011000-00003.
A prospective study of 171 insulin-dependent diabetic pregnant women was undertaken to establish the relationship of glycemic control with minor congenital malformations. Each live-born infant was assessed systematically by two independent examiners using a standardized checklist. There were 32 infants with minor congenital malformations (18.7%). There were significant differences in mean glycohemoglobin A1 between the group with minor congenital malformations and the group without congenital malformations at 12, 16, and 20 weeks, but not at 8 or 24 weeks. Logistic regression analysis showed that maternal age, race, gravidity, White class, duration of diabetes, maternal vasculopathy, and cigarette smoking were not significant variables correlated with minor congenital malformations. Because glycohemoglobin levels from 12-20 weeks are believed to reflect glycemic control from approximately 6-20 weeks, we conclude that poor glycemic control during late embryogenesis and early fetal development is associated with an increased risk of minor congenital malformations. We speculate that improvement of glycemic control during this period should decrease the risk of minor congenital malformations.
对171名胰岛素依赖型糖尿病孕妇进行了一项前瞻性研究,以确定血糖控制与轻微先天性畸形之间的关系。每例活产婴儿由两名独立检查人员使用标准化检查表进行系统评估。有32例婴儿患有轻微先天性畸形(18.7%)。在孕12、16和20周时,有轻微先天性畸形组与无先天性畸形组之间的糖化血红蛋白A1均值存在显著差异,但在孕8周或24周时无差异。逻辑回归分析表明,产妇年龄、种族、妊娠次数、怀特分类、糖尿病病程、产妇血管病变和吸烟不是与轻微先天性畸形相关的显著变量。由于认为孕12至20周的糖化血红蛋白水平反映了大约孕6至20周的血糖控制情况,我们得出结论,胚胎发育晚期和胎儿发育早期血糖控制不佳与轻微先天性畸形风险增加有关。我们推测,在此期间改善血糖控制应会降低轻微先天性畸形的风险。